Ablaze Pharmaceuticals
PrivateLast Round
Series A
Nov 29, 2021
Total Funding Raised
$75M
Company Overview
Ablaze Pharmaceuticals is a biopharmaceutical company specializing in the development of Targeted Radiotherapy (TRT) treatments for cancer patients in the Chinese market.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ablaze Pharmaceuticals Comparables
Compare Ablaze Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AlphaGen Therapeutics | 89% | |
| C-Ray Therapeutics | 88% | |
| Yantai Lannacheng Biotechnology Co., Ltd. | 84% |
Ablaze Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 29, 2021 |
Key People
Founding team and executive leadership
Ablaze Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nan Fung Life Sciences | Series A |
| Advantech Capital | Series A |
| Nan Fung Group | Series A |
| venBio | Series A |
| Venrock | Series A |
| Samsara BioCapital | Series A |
| Vivo Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 29, 2021
$75M round led by Vivo Capital and Advantech Capital.
Ablaze Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ablaze Pharmaceuticals's valuation, stock price, and market status.
Is Aboz Pharmaceuticals a public or private company?
Aboz Pharmaceuticals is a private company.
What is the current stock price of Aboz Pharmaceuticals?
Aboz Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.
How much is Aboz Pharmaceuticals worth (valuation)?
Valuation information for Aboz Pharmaceuticals is not publicly available.
Can I buy Aboz Pharmaceuticals stock?
Aboz Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aboz Pharmaceuticals's last funding round?
Aboz Pharmaceuticals's most recent funding round was Series A on November 29, 2021.
Who are the main investors in Aboz Pharmaceuticals?
Key investors in Aboz Pharmaceuticals include Advantech Capital, Vivo Capital.
Will Aboz Pharmaceuticals IPO soon?
No public IPO plans have been announced for Aboz Pharmaceuticals.
How can I track Aboz Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aboz Pharmaceuticals's secondary market activity and sign up for updates.